Santaris Pharma

Santaris Pharma

Verified
Biopharmaceutical company focused on the discovery and development of rna-targeted therapies.

Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$450m (Public information from Aug 2014)
Company register number 20690003
Hørsholm Capital Region of Denmark (HQ)

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
EUR2016201720182019202020212022
Revenues0000000000000000000000000000
EBITDA0000000000000000000000000000
% EBITDA margin--15 %----
Profit0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000
R&D % of revenue--22 %----

Source: Dealroom estimates

  • Edit
Get premium to view all results
DateInvestorsAmountRound
N/A

$0.0

round
investor investor investor investor investor investor investor investor

$0.0

round
investor investor investor investor investor investor

$0.0

round

$450m

Valuation: $450m

Acquisition
Total Funding000k

Recent News about Santaris Pharma

Edit